- Primary multifocal cystic signet ring neuroendocrine tumor of liver: a case report
-
Bansal N, Satapathy B
- KMID: 2520907
- J Liver Cancer.
- 2021 Sep;21(2):187-193.
- doi: 10.17998/jlc.2021.09.17
Primary signet ring neuroendocrine tumors of the liver are extremely rare tumors. Morphologically, they mimic signet ring cell adenocarcinomas; however, the absence of mucin by special stains and the expression... -
- CITED
-
- Close
- SHARE
-
- Close
- Advances in immune checkpoint inhibitors for hepatocellular carcinoma
-
Han JW, Park SH
- KMID: 2520900
- J Liver Cancer.
- 2021 Sep;21(2):139-145.
- doi: 10.17998/jlc.2021.09.24
Hepatocellular carcinoma (HCC) is the fifth most common cancer, and the second leading cause of cancer-related death worldwide. Although recent advances in immune checkpoint inhibitor-based immunotherapy have initiated a new... -
- CITED
-
- Close
- SHARE
-
- Close
- Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
-
Kim BH, Park JW
- KMID: 2520899
- J Liver Cancer.
- 2021 Sep;21(2):124-138.
- doi: 10.17998/jlc.2021.09.23
Several molecular-targeted agents have been tested as first- or second-line therapies for hepatocellular carcinoma (HCC) but failed to improve clinical outcomes; sorafenib has been the only approved systemic agent for... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term survival after multimodal treatment involving radiotherapy for huge hepatocellular carcinoma with oligometastasis: a case report
-
Lee BM, Seong J
- KMID: 2520903
- J Liver Cancer.
- 2021 Sep;21(2):163-168.
- doi: 10.17998/jlc.2021.08.06
The clinical efficacy of local ablative treatment for oligometastasis is widely accepted in most cancers. However, due to limited data, this has not been the case for hepatocellular carcinoma (HCC).... -
- CITED
-
- Close
- SHARE
-
- Close
- Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report
-
Joo DJ, Kim DY, Seong J, Kim HJ, Lee JG, Han DH, Choi GH, Kim MS, Choi JS, Kim SI
- KMID: 2520906
- J Liver Cancer.
- 2021 Sep;21(2):181-186.
- doi: 10.17998/jlc.2021.09.08
Hepatocellular carcinoma (HCC) with distant metastasis is an absolute contraindication for liver transplantation (LT). However, it is still unclear whether LT is feasible or acceptable in such patients, albeit after... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis
-
Kim SJ, Kim JM
- KMID: 2520897
- J Liver Cancer.
- 2021 Sep;21(2):105-112.
- doi: 10.17998/jlc.2021.03.17
Traditionally, liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis is not recommended. However, with recent developments in locoregional therapies for hepatocellular carcinoma, more aggressive treatments have been attempted... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in radiotherapy application according to regional disease characteristics of hepatocellular carcinoma
-
Rim CH
- KMID: 2520898
- J Liver Cancer.
- 2021 Sep;21(2):113-123.
- doi: 10.17998/jlc.2021.05.26
There are differences in opinion regarding the application of external beam radiotherapy in the treatment of hepatocellular carcinoma. Some major guidelines state that external beam radiotherapy is yet to attain... -
- CITED
-
- Close
- SHARE
-
- Close
- Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report
-
Han JE, Cho HJ, Kim SS, Cheong JY
- KMID: 2520904
- J Liver Cancer.
- 2021 Sep;21(2):169-176.
- doi: 10.17998/jlc.2021.08.26
The current Food and Drug Administration-approved systemic treatments for advanced hepatocellular carcinoma (HCC) include multikinase inhibitors (tyrosine kinase inhibitor [TKI]) and immune checkpoint inhibitors (ICIs). Among ICIs, nivolumab is used... -
- CITED
-
- Close
- SHARE
-
- Close
- Complete response in hepatocellular carcinoma with lymph node metastasis by combination therapy of atezolizumab and bevacizumab: a case report
-
Hwang SY, Lee SM, Lim JW, Jeon GJ, Lee HW
- KMID: 2520905
- J Liver Cancer.
- 2021 Sep;21(2):177-180.
- doi: 10.17998/jlc.2021.09.10
Sorafenib is the oldest first line systemic treatment in patients with advanced hepatocellular carcinoma (HCC) and has been used exclusively for nearly 10 years. The superiority of administering a combination of atezolizumab... -
- CITED
-
- Close
- SHARE
-
- Close
- A case report of a patient presented with skin ulcer after treatment of lenvatinib
-
Cha S, Kim DW, Choe JW, Kim TH, Kim SY, Hyun JJ, Jung SW, Koo JS, Jung YK, Yim HJ
- KMID: 2520908
- J Liver Cancer.
- 2021 Sep;21(2):194-198.
- doi: 10.17998/jlc.2021.09.20
A 60-year-old man diagnosed with unresectable hepatocellular carcinoma (HCC) presented to the hospital with pain in the perineal region. He had been taking lenvatinib every day for 2 months after... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinoma
-
Park JM, Choe WH, Kim JH, Kwon SY, Yoo BC
- KMID: 2520902
- J Liver Cancer.
- 2021 Sep;21(2):155-162.
- doi: 10.17998/jlc.2021.09.22
Background/Aims: Because hepatitis B virus (HBV) replication has been known to play an important role in cancer recurrence after curative treatment of HBV-related hepatocellular carcinoma (HCC), we examined whether treatment based on... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial
-
Kim TH, Kim NH, Kim JD, Kim YN, Kim YJ, Kim EJ, Yoo KD, Ryu CH, Song HH, Kim H
- KMID: 2520901
- J Liver Cancer.
- 2021 Sep;21(2):146-154.
- doi: 10.17998/jlc.2021.05.20
Background/Aims: Surgical resection, transplantation, and radiofrequency ablation (RFA) are generally accepted as amenable treatments for small hepatocellular carcinoma (HCC). Recently drug-eluting beads (DEB) which had several treatment advantages were introduced... -
- CITED
-
- Close
- SHARE
-
- Close
